Abstract
Diabetes remains a burgeoning global problem, necessitating ongoing efforts on the part of pharmaceutical and device manufacturers, patients, and society to curb the frightening trends in morbidity and mortality attributable to the malady. Since 1835 when phlorizin was discovered, sodium glucose co-transporter 2 (SGLT-2) inhibitors have rested tantalizingly on the horizon, promising a more physiological approach to glucose control. These agents lower glucose by enhancing its excretion by blocking reabsorption in the renal tubules, thus eliminating glucose from the body along with the molecules' attendant effects on caloric balance, plasma osmolality, and lipids. Consequently, SGLT-2 inhibitors improve glucose control to an extent comparable to other hypoglycemic agents while simultaneously reducing body weight, blood pressure, and cholesterol - an admirable portfolio. One agent, canagliflozin, has recently been approved by the US Food and Drug Administration (FDA) and two other agents have progressed through Phase III trials, including dapagliflozin and empagliflozin. Collectively, when used as monotherapy, these agents have demonstrated reductions in hemoglobin A1c (HbA1c), body weight, and blood pressure of -0.34% to -1.03%, ...Continue Reading
Citations
May 23, 2014·Drugs·Raewyn M Poole, Jennifer E Prossler
Nov 5, 2014·Indian Journal of Endocrinology and Metabolism·Jayant KelwadeV Sri Nagesh
Jun 29, 2014·Advances in Therapy·Theodoros P Angelopoulos, John Doupis
Sep 26, 2014·International Journal of Endocrinology·Hao-Wen Lin, Chin-Hsiao Tseng
Oct 3, 2014·Drugs·Lesley J Scott
Jun 8, 2015·Diabetes Care·Arthur T SandsPaul Strumph
Nov 2, 2014·Clinical and Experimental Pharmacology & Physiology·Zhi-Xu HeShu-Feng Zhou
Apr 22, 2015·Clinical Therapeutics·Karen WhalenErin St Onge
Nov 4, 2016·Pediatric Diabetes·Fida Bacha, Sara Klinepeter Bartz
Feb 19, 2015·Diabetes, Obesity & Metabolism·M D Sharma
Dec 23, 2014·Clinical Therapeutics·Brian ZambrowiczDavid Powell
May 6, 2016·Frontiers in Endocrinology·Mussa H Almalki, Fahad Alshahrani
Jan 26, 2017·Chemical Reviews·Éva BokorLászló Somsák
May 30, 2020·Postgraduate Medical Journal·Jovanna TsoutsoukiTahseen Ahmad Chowdhury
Jun 23, 2020·Journal of Diabetes·Itivrita GoyalParesh Dandona